Viatris (VTRS) Other Non-Current Assets (2019 - 2026)

Viatris' (VTRS) quarterly Other Non-Current Assets came in at $1.1 billion in Q1 2026, down 51.38% year-on-year from $2.3 billion in Q1 2025, and down 40.92% quarter-over-quarter from $1.9 billion in Q4 2025.

Viatris (VTRS) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Viatris' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 51.38% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 51.38% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 20.58% from the prior year.
  • Other Non-Current Assets retreated to $1.1 billion in Q1 2026 per VTRS's latest filing, from $1.9 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.8 billion in Q4 2023 and bottomed at $230.3 million in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $1.9 billion (2025), against an average of $1.8 billion.
  • Across the five-year window, Other Non-Current Assets slumped 80.33% in 2022 and jumped 1109.73% in 2023, its largest moves.
  • Year by year, Other Non-Current Assets stood at $230.3 million in 2022, then soared by 1109.73% to $2.8 billion in 2023, then retreated by 15.4% to $2.4 billion in 2024, then declined by 20.58% to $1.9 billion in 2025, then slumped by 40.92% to $1.1 billion in 2026.
  • Per Business Quant, the three latest VTRS Other Non-Current Assets figures stand at $1.1 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 377.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 233.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 169,000.00
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 295.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 4.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.11 Bn
Dec 31, 2025 1.87 Bn
Sep 30, 2025 1.89 Bn
Jun 30, 2025 2.00 Bn
Mar 31, 2025 2.27 Bn
Dec 31, 2024 2.36 Bn
Jun 30, 2024 2.45 Bn
Mar 31, 2024 2.52 Bn
Dec 31, 2023 2.79 Bn
Sep 30, 2023 427.30 Mn
Jun 30, 2023 2.35 Bn
Mar 31, 2023 2.42 Bn
Dec 31, 2022 230.30 Mn
Sep 30, 2022 1.43 Bn
Jun 30, 2022 1.47 Bn
Mar 31, 2022 1.34 Bn
Dec 31, 2021 1.17 Bn
Sep 30, 2021 1.04 Bn
Jun 30, 2021 1.03 Bn
Mar 31, 2021 1.02 Bn